ArticleObesity surgery2022

The Safety and Efficacy of Apixaban (Eliquis) in 5017 Post-bariatric Patients with 95.3% Follow-up: a Multicenter Study.

Amit Surve et al.PubMed ↗Publisher ↗

No numbers read from the abstract.